THRESHOLD PHARMACEUTICALS
Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, they are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.
THRESHOLD PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.thresholdpharm.com
Total Employee:
11+
Status:
Closed
Contact:
(650)474-8200
Email Addresses:
[email protected]
Total Funding:
137.75 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Amazon Route 53 Microsoft Squarespace Hosted
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Post-IPO Equity - Threshold Pharmaceuticals
Merck
Merck investment in Post-IPO Equity - Threshold Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Threshold Pharmaceuticals
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Threshold Pharmaceuticals
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Threshold Pharmaceuticals
Sutter Hill Ventures
Sutter Hill Ventures investment in Post-IPO Equity - Threshold Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series B - Threshold Pharmaceuticals
CHL Medical Partners
CHL Medical Partners investment in Series B - Threshold Pharmaceuticals
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Threshold Pharmaceuticals
Pequot Capital
Pequot Capital investment in Series B - Threshold Pharmaceuticals
Official Site Inspections
http://www.thresholdpharm.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
